The present invention is directed to a modified release pharmaceutical composition consisting agglomerates comprising one or more NSAIDs and one or more enteric polymers and process for preparing the same
Abstract of the Invention
The present subject matter defines an apparatus for maintaining and accessing blister-packs and rendering access thereto. The apparatus comprises an enclosure (101) defined by a roof (203) and at least two side-walls (202-1, 2) to receive a sheet (102), wherein said enclosure (101) compris...
The present invention is directed to palatable oral liquid composition comprising divalproex sodium and process for preparing thereof. Particularly, the present invention relates to a stable oral liquid composition, such as solution comprising divalproex sodium and process for preparing thereof.
...
The invention relates to a mixing container. In one embodiment, the container (100) comprises: a housing portion (101) defining a first storage area (103) and a neck portion (102); a cap element (105) being disposed on the neck portion (102) and forming a sealing engagement with the neck portion (102); and a movable...
LIQUID DISPENSING DEVICE FOR DELIVERING ACCURATE DOSE
ABSTRACT
The present invention provides an integrated liquid dispensing device for delivering accurate and/or measured and/or metered and/or pre-determined dose of oral liquids comprising a container for holding liquid medicine and a dispensing device fitted on...
Packaging system for medicaments. The system includes an exchangeable blister pack including a plurality of pockets each housing a unit of medicament. The system includes a processing unit. The blister pack includes a first electric circuit that is wiredly connected to the processing unit. The blister pack includes ...
The present invention relates to a pharmaceutical composition comprising lecithin and process for preparing thereof. The present invention particularly relates a pharmaceutical composition in the form of a liquid dosage form comprising lecithin and one or more pharmaceutically acceptable excipients wherein the lecit...
The present invention relates to a pharmaceutical composition comprising a combination of eperisone or its pharmaceutically acceptable salts and diclofenac or its pharmaceutically acceptable salts and process for preparing thereof.
The present invention discloses a solid oral pharmaceutical composition comprising telmisartan or pharmaceutically acceptable salts thereof, wherein the said compositions are essentially free of surfactants. The present invention further relates to a pharmaceutical composition in the form of tablets comprising telmi...
The present invention provides an integrated dispensing device is adapted for attaching to a container defining an opening and an inner portion and housing therein the multi-particulate substance, and comprisesa cap attachable to the opening of the container, wherein the cap is adapted to receive a dosing head and a...
The present invention relates to taste masked composition comprising prochlorperazine. The present invention further relates to the process for preparing taste masked composition comprising prochlorperazine. The present invention further relates to a process for preparing of taste masked granules comprising prochlor...
The present invention describes an apparatus (104) to enable metered dispensing of liquid. The apparatus includes a first chamber defined by a first cylinder (106) and having a first opening, a second chamber defined by a second cylinder (108) and having a second opening, the second cylinder being enclosed within sa...
Apparatus to enable metered dispensing of viscous substance and a dispenser including the apparatus.
ABSTRACT
An apparatus (100) to enable metered dispensing of a viscous substance comprises a first receptacle (5) defining a first path (6a), a second receptacle (3) enclosing said first receptacle and defining a ...
The present invention relates to a prolonged release pharmaceutical composition comprising Ivabradine and pharmaceutically acceptable salts thereof, wherein said composition is intended for once a day administration. The present invention also relates to a process for preparing prolonged release pharmaceutical compo...
The present invention relates to a pharmaceutical composition of Dipeptidyl peptidase-IV (DPP-IV) inhibitors for use in treatment of Diabetes Mellitus (DM). More particularly, the present invention relates to a modified or extended release dosage form comprising a composition of Vildagliptin or a pharmaceutically ac...
The present invention relates a dispensing assembly for a storage container having a neck portion and a body portion. In one embodiment, the dispensing assembly comprising a tablet tilter being mounted on the neck portion to sealingly engage with the neck portion, the tablet tilter comprising a central shaft dispose...
The present invention relates to chewable composition, preferably in the form of gummies, comprising nutritional ingredients and optionally one or more excipients. wherein the said nutritional ingredients are obtained from vegan sources. Further, the present invention also provides a process for preparation of novel...
The present invention provides the pharmaceutical composition comprising DPP IV inhibitor, optionally in combination with other antidiabetic agent wherein the said composition is easy to administer, patient compliant and cost effective. The present invention also provides the process for preparation of pharmaceutica...
The present invention provides a preservative-free stable topical non-aqueous organogel composition. The present invention further provides a stable topical non-aqueous organogel composition that is free of antioxidants, healing adjuvants, and peroxide. The present invention also provides a process for the preparati...
The present invention provides a composition comprising Octenidine or its pharmaceutically acceptable salts thereof and Metronidazole or its pharmaceutically acceptable salts thereof for managing topical and oral healthcare/hygiene. Furthermore, the present invention provides a preparation process for the said pharm...
[Class : 5] Pharmaceutical Preparations, Medicines For Human Purposes; Sanitary Preparations For Medical Purposes; Dietetic Food And Substances Adapted For Medical Use; Nutraceutical Preparations For Therapeutic Or Medical Purposes; Dietary Supplements; Vitamin Preparations; Plasters, Materials For Dressings.
[Class : 5] Pharmaceuticals, Medical And Veterinary Preparations; Sanitary Preparations For Medical Purposes; Dietetic Food And Substances Adapted For Medical Or Veterinary Use, Food For Babies; Dietary Supplements For Humans And Animals; Plasters, Materials For Dressings; Material For Stopping Teeth, Dental Wax; Disinfectants; Preparations For Destroying Vermin; Fungicides,...
[Class : 5] Pharmaceuticals, Medical And Veterinary Preparations; Sanitary Preparations For Medical Purposes; Dietetic Food And Substances Adapted For Medical Or Veterinary Use, Food For Babies; Dietary Supplements For Humans And Animals; Plasters, Materials For Dressings; Material For Stopping Teeth, Dental Wax; Disinfectants; Preparations For Destroying Vermin; Fungicides,...
View +675 more Brands for Abbott Healthcare Private Limited.
Charges
240 Crore
01 September 2010
Standard Chartered Bank
230 Crore
30 August 2010
Bnp Paribas
10 Crore
12 May 2004
Bnp Paribas
3 Crore
30 August 2010
Bnp Paribas
0
01 September 2010
Standard Chartered Bank
0
12 May 2004
Bnp Paribas
0
30 August 2010
Bnp Paribas
0
01 September 2010
Standard Chartered Bank
0
12 May 2004
Bnp Paribas
0
30 August 2010
Bnp Paribas
0
01 September 2010
Standard Chartered Bank
0
12 May 2004
Bnp Paribas
0
30 August 2010
Bnp Paribas
0
01 September 2010
Standard Chartered Bank
0
12 May 2004
Bnp Paribas
0
Documents
Form DPT-3-17122020-signed
Form AOC-4(XBRL)-26112020_signed
Form MGT-7-25112020_signed
Optional Attachment-(1)-24112020
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-24112020
Optional Attachment-(1)-19112020
List of share holders, debenture holders;-19112020
Copy of MGT-8-19112020
Form MSME FORM I-29102020_signed
Form DIR-12-22102020_signed
Optional Attachment-(2)-19102020
Optional Attachment-(1)-19102020
Form DPT-3-14092020-signed
Form DIR-12-01072020_signed
Optional Attachment-(1)-30062020
Declaration of the appointee director, Managing director, in Form No. DIR-2;-30062020
Form MSME FORM I-16062020_signed
Form DIR-12-06042020_signed
Notice of resignation;-31032020
Evidence of cessation;-31032020
Form MGT-7-20112019_signed
Form MSME FORM I-17112019_signed
Form MSME FORM I-16112019_signed
Copy of MGT-8-08112019
Optional Attachment-(1)-08112019
List of share holders, debenture holders;-08112019
Form AOC-4(XBRL)-26102019_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-23102019